Molecular genetic pathways to Wilms tumor

Area of Science:

• Pediatric oncology
• Developmental biology
• Cancer genetics

Background:

• Wilms tumor serves as a model for gene function in embryogenesis and cancer.
• The initial cloning of the Wilms tumor gene WT1 highlighted the genetic complexity of this childhood kidney cancer.
• Despite evidence for multiple Wilms tumor gene loci, few have been identified and confirmed in human tumorigenesis.

Purpose of the Study:

• To review the genetic complexity of Wilms tumor.
• To discuss the potential role of additional Wilms tumor genes and fetal mitogens like insulin-like growth factor 2.
• To emphasize the need for identifying and understanding the interrelationships of Wilms tumor genes.

Main Methods:

• Review of existing literature on Wilms tumor genetics.
• Discussion of candidate gene properties and their potential involvement in tumorigenesis.
• Analysis of the implications of genetic errors in nephrogenesis.

Main Results:

• The WT1 gene was cloned in 1989, providing a framework but revealing underlying complexity.
• Evidence suggests additional Wilms tumor gene loci exist, though many remain uncharacterized.
• Disregulation of fetal mitogens, such as insulin-like growth factor 2, is a potential factor.

Conclusions:

• Understanding Wilms tumor requires identifying additional contributing genes and their pathways.
• The flexibility of nephrogenesis can accommodate genetic errors, complicating simple mutation models.
• Identifying Wilms tumor gene interactions is essential for developing future therapeutic strategies.